Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Thrombotic Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Looking for participantsNCT07043946
What this trial is testing

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)ITPBiologics+2 more
Climb Bio, Inc. 24
Testing effectiveness (Phase 2)UnknownNCT05932524
What this trial is testing

Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 132
Post-approval studies (Phase 4)Study completedNCT03229746
What this trial is testing

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Assiut University 40
Testing effectiveness (Phase 2)WithdrawnNCT05509582
What this trial is testing

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT01727232
What this trial is testing

Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Henri Mondor University Hospital 107
Large-scale testing (Phase 3)Study completedNCT00102323
What this trial is testing

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 63
Testing effectiveness (Phase 2)Study completedNCT04346654
What this trial is testing

Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 26
Testing effectiveness (Phase 2)Looking for participantsNCT06776510
What this trial is testing

A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableUnknownNCT02967328
What this trial is testing

RP% Measurement by FCM as a Diagnostic Test for ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 500
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Testing effectiveness (Phase 2)UnknownNCT05494307
What this trial is testing

The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 228
Testing effectiveness (Phase 2)UnknownNCT06577909
What this trial is testing

Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 100
Early research (Phase 1)Ended earlyNCT00244257
What this trial is testing

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Genzyme, a Sanofi Company 10
Not applicableStudy completedNCT04845113
What this trial is testing

Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children

Who this might be right for
Idiopathic Purpura
University Hospital, Montpellier 200
Large-scale testing (Phase 3)Study completedNCT05468320
What this trial is testing

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Sanofi 51
Large-scale testing (Phase 3)WithdrawnNCT04274452
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
argenx
Not applicableStudy completedNCT01668615
What this trial is testing

Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
First Affiliated Hospital of Suzhou Medical College 35
Not applicableLooking for participantsNCT04800458
What this trial is testing

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasia
University Hospital, Bordeaux 225
Testing effectiveness (Phase 2)UnknownNCT05369364
What this trial is testing

The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 150
Next Page